Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly

Author： Fry A.M.   Zell E.R.   Schuchat A.   Butler J.C.   Whitney C.G.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.3, 2002-12, pp. : 303-311

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maternal immunization with pneumococcal polysaccharide vaccine in the highlands of Papua New Guinea

By Lehmann D.   Pomat W.S.   Combs B.   Dyke T.   Alpers M.P.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1837-1845

Elsevier

Access to resources Recommend Favorite

Studies of maternal immunisation with pneumococcal polysaccharide vaccine in Papua New Guinea

By Lehmann D.   Pomat W.S.   Riley I.D.   Alpers M.P.  

Vaccine, Vol. 21, Iss. 24, 2003-07 ,pp. : 3446-3450

Elsevier

Access to resources Recommend Favorite

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

By Melegaro Alessia   Edmunds W. John  

European Journal of Epidemiology, Vol. 19, Iss. 4, 2004-04 ,pp. : 365-375

Springer Publishing Company

Access to resources Recommend Favorite

The 23-Valent Pneumococcal Polysaccharide Vaccine. Part I. Efficacy of PPV in the Elderly: A Comparison of Meta-Analyses

By Melegaro Alessia   Edmunds W. John  

European Journal of Epidemiology, Vol. 19, Iss. 4, 2004-04 ,pp. : 353-363

Springer Publishing Company

Access to resources Recommend Favorite

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

By Torling J.   Hedlund J.   Konradsen H.B.   Ortqvist A.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 96-103

Elsevier

Access to resources Recommend Favorite